Byfavo Europese Unie - IJslands - EMA (European Medicines Agency)

byfavo

paion deutschland gmbh - remimazolam besilate - meðvitandi sedation - psycholeptics - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

OxyContin Depot Forðatafla 20 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

oxycontin depot forðatafla 20 mg

mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 20 mg

OxyContin Depot Forðatafla 40 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

oxycontin depot forðatafla 40 mg

mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 40 mg

OxyContin Depot Forðatafla 5 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

oxycontin depot forðatafla 5 mg

mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 5 mg

OxyContin Depot Forðatafla 80 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

oxycontin depot forðatafla 80 mg

mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 80 mg

Strimvelis Europese Unie - IJslands - EMA (European Medicines Agency)

strimvelis

fondazione telethon ets - samgena cd34+ inniheldur klefi brot sem inniheldur cd34+ frumur transduced með retróveira vektor sem umbreytir fyrir mönnum lífvera deaminase (ada) cdna röð frá mönnum skurðaðgerðir stafa/forfaðir (cd34+) frumur - alvarleg samsett ónæmisbrestur - Ónæmisörvandi, - strimvelis er ætlað fyrir meðferð sjúklinga með alvarlega saman ónæmisgalla vegna lífvera deaminase skort (ada-scid), fyrir hvern ekki viðeigandi manna hvítra blóðkorna antigen (hla)-samsvörun tengjast stafa klefi gjafa er í boði (sjá kafla 4. 2 og 4.

Dasatinib Accord Europese Unie - IJslands - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Æxlishemjandi lyf - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.